Project Grant R01DK142666
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, awarded a $728,801 Project Grant to the Regents of the University of Michigan under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a 5-year project to test a novel weight navigation program aimed at overcoming barriers to obesity treatment in primary care settings. The project seeks to improve utilization of effective...
- This $942,000 federal project grant was awarded on September 16, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports a feasibility project at Rush University Medical Center to develop a primary care-based weight management treatment program for individuals discontinuing anti-obesity medications (AOMs). The goal is to quickly identify patients who...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health, awarded a $789,350 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The Pennsylvania State University (Penn State) to investigate biological mechanisms of obesity in a high-risk pediatric cohort with confirmed maltreatment. The project aims to elucidate the impact of child maltreatment on obesity through...
- This $802,363 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a research study at Emory University from September 2025 to June 2030 to develop models for predicting the benefits of GLP-1 receptor agonist (GLP-1RA) treatments in preventing obesity-related cardiometabolic diseases. The study aims to use clinical...
- This $695,295 federal Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which administers the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant was awarded on March 15, 2025 to the Research Foundation for the State University of New York (RF SUNY) to support a research project titled "Developmental Trajectories of Reinforcer Pathology and Childhood Obesity". The project aims to...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $773,112 Project Grant to Rockefeller University on September 5, 2025 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to investigate the mechanisms of transcriptional control in adipocyte formation and function through nuclear receptor coactivators. The research aims to provide a better understanding of dysregulation in energy storage...
- The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $222,500 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Beckman Research Institute of the City of Hope. The grant supports research to understand how conjugated bile acids regulate metabolism after bariatric surgery, with the goal of developing safer and more affordable treatments for obesity and fatty liver disease. Key activities include...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $762,556 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Aurora Health Care, Inc. The award supports the development of a novel, semi-automated self-monitoring feedback system for health promotion in community settings. The project aims to optimize the efficacy of feedback messages related to dietary intake, physical activity, and weight...
- This $804,342 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research at Duke University to investigate the metabolic actions of glucagon, a hormone that plays a key role in glucose regulation. Specifically, the research aims to characterize how glucagon receptor signaling in the liver engages divergent pathways that...
- The federal Project Grant award of $843,485 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support Duke University's evaluation of two novel, population-tailored health insurance designs and their impact on diabetes outcomes among working-age adults. The project aims to assess 10-year trends in the adoption of population-tailored insurance plans that provide more generous benefits to...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $3,145,056 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Duke University. The project aims to collect real-world evidence on the use of anti-obesity medications (AOMs) in adolescents, examining the reach, effectiveness, and potential unintended consequences of these treatments within clinical settings. The 4-year project will recruit a cohort of 200 adolescents (ages 12-17) using AOMs from two pediatric obesity clinics. Key objectives include characterizing the population of youth using AOMs, assessing changes in body composition, diet, physical activity, mental health, and quality of life over an 18-month follow-up period. The grant supports Duke University's research to inform clinical practice, improve health outcomes, and ensure patient safety for adolescents using AOMs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | ($736k) | 9/8/25 | ||
| Not listed | $3.9m | 7/31/25 |